Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health ...

Alumis is advancing ESK-001 for plaque psoriasis with phase 3 data expected in 2026. Read why ALMS stock is compelling yet ...

A huge stock of counterfeit antibiotics worth Rs 1.33 for export was seized by the Drugs Control Administration from the ...

Will Rapamycin Really Help You Live Longer? Despite the lack of human clinical trials, some people already take rapamycin to ...

To potentially include adolescents and antibody persistence up to two years ...

Generic drug repurposing is an underused but promising tool for finding new, affordable therapies. Creating a pull incentive ...